The "Motoric Cognitive Risk" Syndrome in the Canadian Population
NCT ID: NCT03679026
Last Updated: 2024-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1461 participants
OBSERVATIONAL
2017-08-22
2024-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The "Motoric Cognitive Risk" Syndrome in the Quebec Population
NCT03633253
Risk Factors for Falls and Neurocognitive Disorders CLSA
NCT03628768
Cognitive Prefrail and Frailty, and Motoric Cognitive Risk Syndrome: Prevalence and Association With Incident Adverse Health Events
NCT04275817
MCR Syndrome in Quebec : Results From NuAge Study
NCT05046275
Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders
NCT03978650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CVRF
individuals with cardio-vascular risk factors and diseases
Summarize of participants' characteristics using means and standard deviations or frequencies and percentages
Participants' baseline characteristics will be summarized using means and standard deviations or frequencies and percentages, as appropriate.
WCVRF
individuals without cardio-vascular risk factors and diseases
Summarize of participants' characteristics using means and standard deviations or frequencies and percentages
Participants' baseline characteristics will be summarized using means and standard deviations or frequencies and percentages, as appropriate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Summarize of participants' characteristics using means and standard deviations or frequencies and percentages
Participants' baseline characteristics will be summarized using means and standard deviations or frequencies and percentages, as appropriate.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* dementia
* mobility disability
* no information about cognitive complaint
* no measure of walking speed
45 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivier Beauchet
Professor of Geriatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jewish General Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CODIM-FLP-16 261
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.